Does Rallies show Form 4 insider transactions for OM?

Yes. Rallies tracks OM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is OM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.

OM (Outset Medical, Inc. Common Stock) Stock Analysis - Insider Trades

Outset Medical, Inc. Common Stock (OM) is a publicly traded Healthcare sector company. As of May 21, 2026, OM trades at $4.34 with a market cap of $68.96M and a P/E ratio of -1.04. OM moved +13.73% today. Year to date, OM is +15.26%; over the trailing twelve months it is -77.55%. Its 52-week range spans $3.00 to $25.35. Analyst consensus is strong buy with an average price target of $9.50. Rallies surfaces OM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading OM stock inside the company?

Recent OM insider activity includes Trigg Leslie sold 3.44K, Nash Marc sold 1.58K, Brottem John L. sold 2.64K, Brottem John L. sold 2.84K, and Trigg Leslie sold 3.36K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

OM Key Metrics

Key financial metrics for OM
Metric	Value
Price	$4.34
Market Cap	$68.96M
P/E Ratio	-1.04
EPS	$-4.07
Dividend Yield	0.00%
52-Week High	$25.35
52-Week Low	$3.00
Volume	224
Avg Volume	0
Revenue (TTM)	$117.59M
Net Income	$-74.85M
Gross Margin	40.64%

Recent OM Insider Trades

Trigg Leslie sold 3.44K (~$12.75K) on May 15, 2026.
Nash Marc sold 1.58K (~$5.85K) on May 15, 2026.
Brottem John L. sold 2.64K (~$9.76K) on May 15, 2026.
Brottem John L. sold 2.84K (~$9.52K) on Feb 17, 2026.
Trigg Leslie sold 3.36K (~$11.26K) on Feb 17, 2026.

Latest OM News

Outset Medical Q1 Revenue Drops 6% to $27.9M, Gross Margin Rises to 43.4% — May 7, 2026
Analysts Project $28.9M Q1 Revenue for Outset Medical, Price Target of $9.00 — May 6, 2026
Outset Medical appoints Derick Elliott EVP to expand Tablo in nearly 1,000 facilities — Apr 6, 2026
Outset Medical Q4 Margins Jump 600bps, Price Targets Cut to $12 and $15 — Feb 20, 2026
Stifel Cuts Outset Medical Price Target to $8, Keeps Buy Rating — Feb 9, 2026

OM Analyst Consensus

4 analysts cover OM: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.50.

Common questions about OM

Who is trading OM stock inside the company?: Recent OM insider activity includes Trigg Leslie sold 3.44K, Nash Marc sold 1.58K, Brottem John L. sold 2.64K, Brottem John L. sold 2.84K, and Trigg Leslie sold 3.36K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for OM?: Yes. Rallies tracks OM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is OM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.